E-Newsletter - March 2022
FY22 BIQSFP Funding Opportunity

FY22 BIQSFP Funding Opportunity | Non-Real Time (NRT) Integrated Studies

A one-time FY22 opportunity for BIQSFP supplement awards to support non-real time (NRT) integrated studies associated with randomized, phase 2 or 3 trials conducted by NCTN Groups and NCORP Research Bases i now available. NCI plans to make 3-5 supplements by September 30, 2022, and the maximum budget allowed is $500,000 in direct costs (not including subaward F&As) per supplement. These supplements will be for one year only (no outyear funding).

Given the limited number of awards that will be made, the maximum number of applications accepted will be as follows: 

NCTN – Each NCTN Network Group may submit up to 3 applications.
NCORP – Each NCORP Research Base may submit up to 2 applications. 

The application deadline due to NCI is June 6, 2022 and a letter of intent to be submitted to NCI by May 27, 2022. Additional details can be found in the attached announcement. 

Alliance members: To allow Alliance scientific and operations leadership to select and prepare the final applications to be submitted on the behalf of the Alliance, a letter of intent, final BIQSFP checklist, and a draft budget for the project must be submitted by e-mail to Dr. Yujia Wen (Senior Director, Translational Research Operations) at ywen@bsd.uchicago.edu by May 18, 2022, 5 pm CT. Please include “FY22 NRT BIQSFP” in the e-mail subject line. 

Applications forms and instructions can be downloaded from the NCI BIQSFP website: https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp.  It will be greatly appreciated (though not required) if you can let Dr. Wen know your interests by e-mail as soon as possible (preferably by May 2, 2022).  Final applicants for the Alliance will be notified during the week of May 23, 2022 to prepare for the final submission. 

If you have any questions regarding this announcement, please contact Dr. Wen at the Alliance, Dr. Kelly Kim (240-276-7811), Ms. Beverly Lee (240-620-0561) at the NCI, or send an e-mail to NCIBIQSFP@mail.nih.gov.


For other articles in this issue of the Alliance E-News newsletter, see below.